AAAAAA

   
Results: 1-25 | 26-43
Results: 1-25/43

Authors: BAXTER GS FAIRWEATHER PG
Citation: Gs. Baxter et Pg. Fairweather, DOES AVAILABLE FORAGING AREA, LOCATION OR COLONY CHARACTER CONTROL THE SIZE OF MULTISPECIES EGRET COLONIES, Wildlife research, 25(1), 1998, pp. 23-32

Authors: BOWEN WP MCMURRAY HF LALL S BAXTER GS COLEMAN RA
Citation: Wp. Bowen et al., PHARMACOLOGICAL MODULATION OF CHLORIDE-ION EFFLUX FROM T84 CELLS, British Journal of Pharmacology, 123, 1998, pp. 32-32

Authors: BAXTER GS COLEMAN RA MIAH A MURPHY OE CAREY JE
Citation: Gs. Baxter et al., REGIONAL DISTRIBUTION OF 5-HT2C RECEPTOR MESSENGER-RNA IN HUMAN TISSUES USING REAL-TIME, QUANTITATIVE SEQUENCE DETECTION, British Journal of Pharmacology, 123, 1998, pp. 112-112

Authors: CAREY JE MIAH A MURPHY OE COLEMAN RA BAXTER GS
Citation: Je. Carey et al., QUANTIFICATION OF MESSENGER-RNA TRANSCRIPT COPY NUMBER USING THE ABI PRISM(TM) SEQUENCE DETECTION SYSTEM, British Journal of Pharmacology, 123, 1998, pp. 113-113

Authors: MURPHY OE CAREY JE MIAH A COLEMAN RA BAXTER GS
Citation: Oe. Murphy et al., ASSESSMENT OF SAMPLE QUALITY OF TOTAL RNA FOR MESSENGER-RNA EXPRESSION STUDIES, British Journal of Pharmacology, 123, 1998, pp. 114-114

Authors: DUXON MS FLANIGAN TP REAVLEY AC BAXTER GS BLACKBURN TP FONE KCF
Citation: Ms. Duxon et al., EVIDENCE FOR EXPRESSION OF THE 5-HYDROXYTRYPTAMINE-2B RECEPTOR PROTEIN IN THE RAT CENTRAL-NERVOUS-SYSTEM, Neuroscience, 76(2), 1997, pp. 323-329

Authors: HARMER DW BOWEN WP COLEMAN RA BAXTER GS
Citation: Dw. Harmer et al., DEVELOPMENT OF A HIGH-THROUGHPUT IMMUNOBLOTTING SYSTEM SUITABLE FOR THE DETECTION AND QUANTIFICATION OF PROTEINS IN HUMAN TISSUE, British Journal of Pharmacology, 122, 1997, pp. 263-263

Authors: CASTRO SW ALI M BOWEN WP COLEMAN RA BAXTER GS
Citation: Sw. Castro et al., DIFFERENCES IN THE PHARMACOLOGICAL PROFILES OF HUMAN LUNG MEMBRANES FROM SMOKERS AND NONSMOKERS, British Journal of Pharmacology, 122, 1997, pp. 268-268

Authors: READ SJ BULMER DCE RUSHTON S SMITH MI BAXTER GS SMITH S PARSONS AA
Citation: Sj. Read et al., 5-HT, OR THE 5-HT2B RECEPTOR AGONIST, BW 723C86, DO NOT ALTER MARKER EXTRAVASATION IN RAT DURA-MATER, British Journal of Pharmacology, 120, 1997, pp. 214-214

Authors: BAXTER GS
Citation: Gs. Baxter, PROVISION OF SUPPLEMENTARY NEST MATERIAL TO COLONIAL EGRETS, Emu, 96, 1996, pp. 145-150

Authors: FORBES IT DABBS S DUCKWORTH DM HAM P JONES GE KING FD SAUNDERS DV BLANEY FE NAYLOR CB BAXTER GS BLACKBURN TP KENNETT GA WOOD MD
Citation: It. Forbes et al., SYNTHESIS, BIOLOGICAL-ACTIVITY, AND MOLECULAR MODELING STUDIES OF SELECTIVE 5-HT2C 2B RECEPTOR ANTAGONISTS/, Journal of medicinal chemistry, 39(25), 1996, pp. 4966-4977

Authors: THOMAS DR BAXTER GS CAREY JE GAGER TL GALE DG HOLLAND V MUIR A WILSON S WOOD MD
Citation: Dr. Thomas et al., SB 204741 IS A SELECTIVE ANTAGONIST AT THE CLONED HUMAN 5-HT2B RECEPTOR STABLY EXPRESSED IN HEK-293 CELLS, British Journal of Pharmacology, 117, 1996, pp. 137-137

Authors: AINSWORTH K TRAIL B BLACKBURN TP BAXTER GS KENNETT GA
Citation: K. Ainsworth et al., IS BW 723C86-INDUCED HYPERPHAGIA AN IN-VIVO MODEL OF RAT CENTRAL 5-HT2B RECEPTOR FUNCTION, British Journal of Pharmacology, 117, 1996, pp. 178-178

Authors: ELLIS ES TILFORD NS BAXTER GS SANGER GJ
Citation: Es. Ellis et al., A COMPARISON OF N-TYPE CALCIUM CHANNELS IN HUMAN AND RAT ISOLATED VAS-DEFERENS BY RANK ORDER OF OMEGA-CONOTOXIN ACTIVITY, British Journal of Pharmacology, 117, 1996, pp. 204-204

Authors: KENNETT GA BRIGHT F TRAIL B BAXTER GS BLACKBURN TP
Citation: Ga. Kennett et al., EFFECTS OF THE 5-HT2B RECEPTOR AGONIST, BW-723C86, ON 3 RAT MODELS OFANXIETY, British Journal of Pharmacology, 117(7), 1996, pp. 1443-1448

Authors: KENNETT GA WOOD MD BRIGHT F CILIA J PIPER DC GAGER T THOMAS D BAXTER GS FORBES IT HAM P BLACKBURN TP
Citation: Ga. Kennett et al., IN-VITRO AND IN-VIVO PROFILE OF SB-206553, A POTENT 5-HT2C 5-HT2B RECEPTOR ANTAGONIST WITH ANXIOLYTIC-LIKE PROPERTIES/, British Journal of Pharmacology, 117(3), 1996, pp. 427-434

Authors: BAXTER GS TILFORD NS
Citation: Gs. Baxter et Ns. Tilford, ENDOGENOUS LIGANDS AND INVERSE AGONISM, Trends in pharmacological sciences, 16(8), 1995, pp. 258-259

Authors: BAXTER GS
Citation: Gs. Baxter, NOVEL DISCRIMINATORY LIGANDS FOR 5-HT2B RECEPTORS, Behavioural brain research, 73(1-2), 1995, pp. 149-152

Authors: FORBES IT JONES GE MURPHY OE HOLLAND V BAXTER GS
Citation: It. Forbes et al., METHYL-5-INDOLYL)-N'-(3-METHYL-5-ISOTHIAZOLYL)UREA - A NOVEL, HIGH-AFFINITY 5-HT2B RECEPTOR ANTAGONIST, Journal of medicinal chemistry, 38(6), 1995, pp. 855-857

Authors: FORBES IT HAM P BOOTH DH MARTIN RT THOMPSON M BAXTER GS BLACKBURN TP GLEN A KENNETT GA WOOD MD
Citation: It. Forbes et al., LCARBAMOYL)-1,2,3,5-TETRAHYDROPYRROLO[2,3-F]INDOLE - A NOVEL 5-HT2C 5-HT2B RECEPTOR ANTAGONIST WITH IMPROVED AFFINITY, SELECTIVITY, AND ORAL ACTIVITY, Journal of medicinal chemistry, 38(14), 1995, pp. 2524-2530

Authors: KENNETT GA BRIGHT F TRAIL B BLACKBURN TP BAXTER GS
Citation: Ga. Kennett et al., EFFECTS OF THE 5-HT2B RECEPTOR AGONIST, BW 723C86, IN RAT SOCIAL-INTERACTION, ELEVATED X-MAZE AND GELLER-SEIFTER MODELS OF ANXIETY, British Journal of Pharmacology, 116, 1995, pp. 330-330

Authors: DUXON MS BECKETT SR BAXTER GS BLACKBURN TP FONE KCF
Citation: Ms. Duxon et al., INTRAAMYGDALA INJECTION OF THE 5-HT2B RECEPTOR AGONIST BW-72386 PRODUCES ANXIOLYSIS ON THE ELEVATED PLUS-MAZE IN THE RAT, British Journal of Pharmacology, 116, 1995, pp. 331-331

Authors: TRAIL B AINSWORTH K BLACKBURN TP BAXTER GS KENNETT GA
Citation: B. Trail et al., ARE MCPP-INDUCED BEHAVIORS 5-HT2C OR 5-HT2B RECEPTOR-MEDIATED, British Journal of Pharmacology, 116, 1995, pp. 449-449

Authors: BAXTER GS CLAYTON JK COLEMAN RA MARSHALL K SANGHA R SENIOR J
Citation: Gs. Baxter et al., CHARACTERIZATION OF THE PROSTANOID RECEPTORS MEDIATING CONSTRICTION AND RELAXATION OF HUMAN ISOLATED UTERINE ARTERY, British Journal of Pharmacology, 116(1), 1995, pp. 1692-1696

Authors: BAXTER GS BLACKBURN TP CHAPMAN J TILFORD NS
Citation: Gs. Baxter et al., CONTRACTILE ACTIONS OF THE MIXED 5-HT2A 2B/2C RECEPTOR ANTAGONIST ICI-169369 IN RAT STOMACH FUNDUS/, British Journal of Pharmacology, 115, 1995, pp. 130-130
Risultati: 1-25 | 26-43